[1] 张奉春.类风湿性关节炎的基础与临床研究进展[J].中国医药信息导报,2007,22:21.
[2] 吕方,李兴福.2010年美国风湿病学会联合欧洲抗风湿病联盟的类风湿关节炎分类标准解读[J].诊断学理论与实践,2010,9(4):307.
[3] CHO SY,KANG SY,LEE HJ,et al.A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis[J].Korean J Lab Med,2008,28(1):39.
[4] GOLDBACH-MANSKY R,LEE J,MCCOY A,et al.Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset[J].Arthritis Res,2000,2(2):236.
[5] POLIDO-PEREIRA J,VIEIRA-SOUSA E,FONSECA JE.Rheumatoid arthritis:what is refractory disease and how to manage it?[J].Autoimmun Rev,2011,10(11):707.
[6] 张炯,邹和建,陈宇明,等.抗环瓜氨酸肽抗体和葡萄糖-6-磷酸异构酶抗原对类风湿关节炎诊断价值的比较[J].中华风湿病学杂志,2008,12(1):33.
[7] VOSSRNAAR ER,DESPRES N,LAPOINTE E,et al.Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin[J].Arthritis Res Ther,2004,6(2):1.
[8] 蒋红英,石青峰.3种血清指标检测在类风湿关节炎诊断中的应用[J].检验医学与临床,2011,8(11):1322.
[9] 黄晶,林花,王永新,等.抗环瓜氨酸肽抗体、抗角蛋白抗体、抗核周因子抗体和类风湿因子联合检测在老年类风湿关节炎诊断中的意义[J].中国老年学杂志,2010,30(10):1362.
[10] 钱龙,史恒星,李向培,等.类风湿关节炎患者血清肽酰基精氨酸脱亚氨酶-4水平及其意义[J].中华内科杂志,2011,50(2):107.